Spironolactone for heart failure with preserved ejection fraction

N Engl J Med. 2014 Jul 10;371(2):179-80. doi: 10.1056/NEJMc1405715.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Heart Failure / drug therapy*
  • Humans
  • Male
  • Mineralocorticoid Receptor Antagonists / therapeutic use*
  • Spironolactone / therapeutic use*

Substances

  • Mineralocorticoid Receptor Antagonists
  • Spironolactone